Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 10

2022 May-2 - 224 articles

Cover Story: Ovarian cancer exhibits one of the lowest survival rates amongst all cancer types, and over the last 30 years, little progress has been made to improve treatment efficacy. This indicates that a paradigm shift is required to treat this devastating disease. Recent research has revealed the presence of numerous overexpressed G-protein coupled receptors (GPCRs) in ovarian cancer tissues, which may highlight a new treatment paradigm that uses GPCRs as molecular entry points to deliver cancer therapeutics into ovarian cancer cells with engineered nanoparticles (NPs). Due to the genetic heterogeneity in ovarian cancers, personalized treatments are required that are based on target receptor expression analysis in cancer tissues, followed by the design of modular GPCR-targeted, drug-loaded NPs on a case-by-case basis. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (224)

  • Article
  • Open Access
11 Citations
3,011 Views
12 Pages

Enucleation Is a Feasible Procedure for Well-Differentiated pNEN—A Matched Pair Analysis

  • Anna Nießen,
  • Fabiola A. Bechtiger,
  • Ulf Hinz,
  • Magdalena Lewosinska,
  • Franck Billmann,
  • Thilo Hackert,
  • Markus W. Büchler and
  • Simon Schimmack

23 May 2022

The extent of surgical resection in the treatment of pancreatic neuroendocrine neoplasms (pNEN) is still controversial. This study aimed to evaluate the outcomes of enucleation for well-differentiated non-functional (nf) pNEN. Patients undergoing enu...

  • Review
  • Open Access
426 Citations
65,970 Views
27 Pages

23 May 2022

Breast cancer is the most-commonly diagnosed malignant tumor in women in the world, as well as the first cause of death from malignant tumors. The incidence of breast cancer is constantly increasing in all regions of the world. For this reason, despi...

  • Article
  • Open Access
10 Citations
2,998 Views
16 Pages

Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy

  • Antonella Brunello,
  • Antonella Galiano,
  • Stefania Schiavon,
  • Mariateresa Nardi,
  • Alessandra Feltrin,
  • Ardi Pambuku,
  • Chiara De Toni,
  • Alice Dal Col,
  • Evelina Lamberti and
  • Vittorina Zagonel
  • + 12 authors

23 May 2022

Benefits of early palliative care referral in oncology are well-validated. At the Veneto Institute of Oncology-IRCCS, a simultaneous-care outpatient clinic (SCOC) has been active since 2014, where patients with advanced cancer are evaluated by an onc...

  • Article
  • Open Access
12 Citations
2,733 Views
14 Pages

Modifiers of and Disparities in Palliative and Supportive Care Timing and Utilization among Neurosurgical Patients with Malignant Central Nervous System Tumors

  • Michael Chuwei Jin,
  • Gary Hsin,
  • John Ratliff,
  • Reena Thomas,
  • Corinna Clio Zygourakis,
  • Gordon Li and
  • Adela Wu

23 May 2022

Patients with primary or secondary central nervous system (CNS) malignancies benefit from utilization of palliative care (PC) in addition to other supportive services, such as home health and social work. Guidelines propose early initiation of PC for...

  • Article
  • Open Access
17 Citations
3,276 Views
20 Pages

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

  • Cristina Banella,
  • Gianfranco Catalano,
  • Serena Travaglini,
  • Elvira Pelosi,
  • Tiziana Ottone,
  • Alessandra Zaza,
  • Gisella Guerrera,
  • Daniela Francesca Angelini,
  • Pasquale Niscola and
  • Nelida Ines Noguera
  • + 7 authors

23 May 2022

In the present study, we characterized the metabolic background of different Acute Myeloid Leukemias’ (AMLs) cells and described a heterogeneous and highly flexible energetic metabolism. Using the Seahorse XF Agilent, we compared the metabolism...

  • Systematic Review
  • Open Access
13 Citations
4,919 Views
19 Pages

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis

  • Surapon Nochaiwong,
  • Mati Chuamanochan,
  • Chidchanok Ruengorn,
  • Kajohnsak Noppakun,
  • Ratanaporn Awiphan,
  • Chabaphai Phosuya,
  • Napatra Tovanabutra,
  • Siri Chiewchanvit,
  • Manish M. Sood and
  • Greg A. Knoll
  • + 2 authors

23 May 2022

Background: The use of thiazide diuretics is associated with skin cancer risk; however, whether this applies to all skin cancer types is unclear. Methods: In this meta-analysis, we searched multiple electronic databases and gray literature up to 10 A...

  • Review
  • Open Access
17 Citations
8,209 Views
19 Pages

The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes

  • Salvatore Cozzi,
  • Matteo Augugliaro,
  • Patrizia Ciammella,
  • Andrea Botti,
  • Valeria Trojani,
  • Masoumeh Najafi,
  • Gladys Blandino,
  • Maria Paola Ruggieri,
  • Lucia Giaccherini and
  • Lilia Bardoscia
  • + 7 authors

23 May 2022

Breast cancer represents the second leading cause of cancer-related death in the female population, despite continuing advances in treatment options that have significantly accelerated in recent years. Conservative treatments have radically changed t...

  • Viewpoint
  • Open Access
15 Citations
5,851 Views
29 Pages

MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

  • Richard E. Kast,
  • Alex Alfieri,
  • Hazem I. Assi,
  • Terry C. Burns,
  • Ashraf M. Elyamany,
  • Maria Gonzalez-Cao,
  • Georg Karpel-Massler,
  • Christine Marosi,
  • Michael E. Salacz and
  • Marc-Eric Halatsch
  • + 3 authors

23 May 2022

In part one of this two-part paper, we present eight principles that we believe must be considered for more effective treatment of the currently incurable cancers. These are addressed by multidrug adjunctive cancer treatment (MDACT), which uses multi...

  • Article
  • Open Access
15 Citations
5,885 Views
23 Pages

GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells

  • Chiara Bellio,
  • Marta Emperador,
  • Pol Castellano,
  • Albert Gris-Oliver,
  • Francesc Canals,
  • Alex Sánchez-Pla,
  • Esther Zamora,
  • Joaquín Arribas,
  • Cristina Saura and
  • Josep Villanueva
  • + 3 authors

23 May 2022

Drug tolerant persister (DTP) cells enter into a reversible slow-cycling state after drug treatment. We performed proteomic characterization of the breast cancer (BC) DTP cell secretome after eribulin treatment. We showed that the growth differentiat...

  • Review
  • Open Access
6 Citations
4,804 Views
19 Pages

Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?

  • Chao Yin,
  • Monika Kulasekaran,
  • Tina Roy,
  • Brennan Decker,
  • Sonja Alexander,
  • Mathew Margolis,
  • Reena C. Jha,
  • Gary M. Kupfer and
  • Aiwu R. He

23 May 2022

Biliary tract cancers (BTCs) are a heterogeneous group of malignancies that make up ~7% of all gastrointestinal tumors. It is notably aggressive and difficult to treat; in fact, >70% of patients with BTC are diagnosed at an advanced, unresectable...

  • Systematic Review
  • Open Access
14 Citations
3,482 Views
15 Pages

The Effect of Adjuvant Chemotherapy on Localized Extraskeletal Osteosarcoma: A Systematic Review

  • Shinji Tsukamoto,
  • Andreas F. Mavrogenis,
  • Lucia Angelelli,
  • Alberto Righi,
  • Giuseppe Filardo,
  • Akira Kido,
  • Kanya Honoki,
  • Yuu Tanaka,
  • Yasuhito Tanaka and
  • Costantino Errani

23 May 2022

(1) Background: Extraskeletal osteosarcoma (ESOS) is a malignant tumor characterized by the production of bone or bone matrix by tumor cells without any continuity into the skeletal bones. The standard treatment for localized ESOS is wide resection;...

  • Review
  • Open Access
81 Citations
9,724 Views
18 Pages

Glutathione Peroxidase GPX1 and Its Dichotomous Roles in Cancer

  • Yangjing Zhao,
  • Hui Wang,
  • Jingdong Zhou and
  • Qixiang Shao

23 May 2022

As the first identified selenoprotein, glutathione peroxidase 1 (GPX1) is a widely and abundantly expressed antioxidant enzyme. GPX1 utilizes glutathione as a substrate to catalyze hydrogen peroxide, lipid peroxide, and peroxynitrite, thereby reducin...

  • Article
  • Open Access
5 Citations
4,127 Views
16 Pages

COVID-19 Vaccination in Patients with Cancer

  • Hitomi Suzuki,
  • Tomohiro Akiyama,
  • Nobuko Ueda,
  • Satoko Matsumura,
  • Miki Mori,
  • Masatoshi Namiki,
  • Norikazu Yamada,
  • Chika Tsutsumi,
  • Satoshi Tozaki and
  • Kiyosuke Ishiguro
  • + 3 authors

23 May 2022

Patients with cancer are concerned about the effects of the COVID-19 vaccination. We conducted an online survey on the COVID-19 vaccination status and side effects among patients with cancer in Japan between 8 and 14 August 2021. We included 1182 fem...

  • Article
  • Open Access
8 Citations
2,439 Views
12 Pages

Viral and Genomic Drivers of Squamous Cell Neoplasms Arising in the Lacrimal Drainage System

  • Ingvild Ramberg,
  • Filipe Garrett Vieira,
  • Peter Bjerre Toft,
  • Christian von Buchwald and
  • Steffen Heegaard

23 May 2022

The pathogenesis of squamous cell neoplasms arising in the lacrimal drainage system is poorly understood, and the underlying genomic drivers for disease development remain unexplored. We aimed to investigate the genomic aberrations in carcinomas aris...

  • Article
  • Open Access
13 Citations
4,325 Views
8 Pages

Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases

  • Aurélie Balmer,
  • Daniel Clerc,
  • Laura Toussaint,
  • Olivia Sgarbura,
  • Abdelkader Taïbi,
  • Martin Hübner and
  • Hugo Teixeira Farinha

23 May 2022

Background: The standard treatment protocol for PIPAC consists of three procedures. Completion of treatment has been shown to be prognostic of improved survival. The aim of this study was to identify predictors for completion of treatment. Methods: R...

  • Article
  • Open Access
4 Citations
2,821 Views
13 Pages

Associations of Physical Activity and Handgrip Strength with Different Domains of Quality of Life in Pediatric Cancer Survivors

  • Ankie Tan Cheung,
  • William Ho Cheung Li,
  • Laurie Long Kwan Ho,
  • Wei Xia,
  • Yuanhui Luo,
  • Godfrey Chi Fung Chan and
  • Joyce Oi Kwan Chung

23 May 2022

There is a paucity of evidence about the associations of physical activity (PA) and handgrip strength (HGS) within different domains of quality of life (QoL) in Chinese pediatric cancer survivors. We, therefore, conducted this multicenter cross-secti...

  • Article
  • Open Access
22 Citations
4,005 Views
13 Pages

Deep-Learning-Based Automatic Detection and Segmentation of Brain Metastases with Small Volume for Stereotactic Ablative Radiotherapy

  • Sang Kyun Yoo,
  • Tae Hyung Kim,
  • Jaehee Chun,
  • Byong Su Choi,
  • Hojin Kim,
  • Sejung Yang,
  • Hong In Yoon and
  • Jin Sung Kim

23 May 2022

Recently, several efforts have been made to develop the deep learning (DL) algorithms for automatic detection and segmentation of brain metastases (BM). In this study, we developed an advanced DL model to BM detection and segmentation, especially for...

  • Review
  • Open Access
10 Citations
3,509 Views
12 Pages

Strategies to Achieve Breast Health Equity in the St. Louis Region and Beyond over 15+ Years

  • Bettina Drake,
  • Aimee James,
  • Heidi Miller,
  • Akila Anandarajah,
  • Kia L. Davis,
  • Sheryll Jackson,
  • Graham A Colditz and
  • Vetta Sanders Thompson

23 May 2022

Community-based participatory strategies are a promising approach to addressing disparities in community health outcomes. This paper details the efforts of Siteman Cancer Center to achieve breast health equity over the past 15+ years. We begin by des...

  • Article
  • Open Access
11 Citations
3,393 Views
15 Pages

Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma

  • Chih-Hsiung Su,
  • Wan-Ming Chen,
  • Mingchih Chen,
  • Ben-Chang Shia and
  • Szu-Yuan Wu

22 May 2022

Purpose: The survival impact of diabetes severity on lung cancer remains unclear. We performed head-to-head propensity score matching to estimate the survival impact of various adapted diabetes complications severity index (aDCSI) scores in patients...

  • Article
  • Open Access
4 Citations
2,520 Views
15 Pages

Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors

  • Niko Hiltunen,
  • Jukka Rintala,
  • Juha P. Väyrynen,
  • Jan Böhm,
  • Tuomo J. Karttunen,
  • Heikki Huhta and
  • Olli Helminen

22 May 2022

Monocarboxylate transporters (MCTs) are cell membrane proteins transporting lactate, pyruvate, and ketone bodies across the plasma membrane. The prognostic role of MCTs in neuroendocrine tumors is unknown. We aimed to analyze MCT1 and MCT4 expression...

  • Article
  • Open Access
10 Citations
4,087 Views
15 Pages

Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma

  • Qingwen Xu,
  • Yuxi Liu,
  • Wen Sun,
  • Tiantian Song,
  • Xintong Jiang,
  • Kui Zeng,
  • Su Zeng,
  • Lu Chen and
  • Lushan Yu

22 May 2022

Hypoxic microenvironment and metabolic dysregulation of tumor impairs the therapeutic efficacy of chemotherapeutic drugs, resulting in drug resistance and tumor metastasis, which has always been a challenge for the treatment of solid tumors, includin...

  • Review
  • Open Access
20 Citations
4,588 Views
12 Pages

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

  • Ryota Masuzaki,
  • Tatsuo Kanda,
  • Reina Sasaki,
  • Naoki Matsumoto,
  • Kazushige Nirei,
  • Masahiro Ogawa,
  • Seth J. Karp,
  • Mitsuhiko Moriyama and
  • Hirofumi Kogure

22 May 2022

Cytokines are secreted soluble glycoproteins that regulate cellular growth, proliferation, and differentiation. Suppressors of cytokine signaling (SOCS) proteins negatively regulate cytokine signaling and form a classical negative feedback loop in th...

  • Review
  • Open Access
20 Citations
4,523 Views
15 Pages

22 May 2022

Soft tissue sarcomas are malignant tumors of mesenchymal origin, encompassing a large spectrum of entities that were historically classified according to their histological characteristics. Over the last decades, molecular biology has allowed a bette...

  • Article
  • Open Access
6 Citations
2,436 Views
11 Pages

Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials

  • Dirk Rades,
  • Jon Cacicedo,
  • Darejan Lomidze,
  • Ahmed Al-Salool,
  • Barbara Segedin,
  • Blaz Groselj and
  • Steven E. Schild

22 May 2022

For optimal personalization of treatment for metastatic spinal cord compression (MSCC), the patient’s survival prognosis should be considered. Estimation of survival can be facilitated by prognostic factors. This study investigated the prognost...

  • Review
  • Open Access
4 Citations
4,851 Views
24 Pages

Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives

  • Joaquim Soares do Brito,
  • Miguel Esperança-Martins,
  • André Abrunhosa-Branquinho,
  • Cecilia Melo-Alvim,
  • Raquel Lopes-Brás,
  • João Janeiro,
  • Dolores Lopez-Presa,
  • Isabel Fernandes,
  • José Portela and
  • Luis Costa

22 May 2022

Bone sarcomas (BS) are rare mesenchymal tumors usually located in the extremities and pelvis. While surgical resection is the cornerstone of curative treatment, some locally advanced tumors are deemed unresectable and hence not suitable for curative...

  • Review
  • Open Access
49 Citations
5,952 Views
14 Pages

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review

  • Biagio Barone,
  • Armando Calogero,
  • Luca Scafuri,
  • Matteo Ferro,
  • Giuseppe Lucarelli,
  • Erika Di Zazzo,
  • Enrico Sicignano,
  • Alfonso Falcone,
  • Lorenzo Romano and
  • Felice Crocetto
  • + 5 authors

21 May 2022

Bladder cancer is the ninth most common cancer worldwide. Over 75% of non-muscle invasive cancer patients require conservative local treatment, while the remaining 25% of patients undergo radical cystectomy or radiotherapy. Immune checkpoint inhibito...

  • Article
  • Open Access
23 Citations
4,991 Views
18 Pages

21 May 2022

Glioblastoma multiforme (GBM) is one of the most aggressive forms of cancer. Neurotransmitters (NTs) have recently been linked with the uncontrolled proliferation of cancer cells, but the role of NTs in the progression of human gliomas is still large...

  • Article
  • Open Access
32 Citations
5,061 Views
29 Pages

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

  • Johannes F. Fahrmann,
  • Ichidai Tanaka,
  • Ehsan Irajizad,
  • Xiangying Mao,
  • Jennifer B. Dennison,
  • Eunice Murage,
  • Julian Casabar,
  • Jeffrey Mayo,
  • Qian Peng and
  • Edwin J. Ostrin
  • + 12 authors

21 May 2022

Activation of the NRF2 pathway through gain-of-function mutations or loss-of-function of its suppressor KEAP1 is a frequent finding in lung cancer. NRF2 activation has been reported to alter the tumor microenvironment. Here, we demonstrated that NRF2...

  • Article
  • Open Access
7 Citations
5,521 Views
22 Pages

Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature

  • Rafael Stroggilos,
  • Maria Frantzi,
  • Jerome Zoidakis,
  • Marika Mokou,
  • Napoleon Moulavasilis,
  • Emmanouil Mavrogeorgis,
  • Anna Melidi,
  • Manousos Makridakis,
  • Konstantinos Stravodimos and
  • Antonia Vlahou
  • + 2 authors

21 May 2022

Despite advancements in molecular classification, tumor stage and grade still remain the most relevant prognosticators used by clinicians to decide on patient management. Here, we leverage publicly available data to characterize bladder cancer (BLCA)...

  • Article
  • Open Access
11 Citations
2,659 Views
13 Pages

Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3

  • Miran Rada,
  • Audrey Kapelanski-Lamoureux,
  • Migmar Tsamchoe,
  • Stephanie Petrillo,
  • Anthoula Lazaris and
  • Peter Metrakos

21 May 2022

Resistance to anti-angiogenic therapy is a major challenge in the treatment of colorectal cancer liver metastases (CRCLMs). Vessel co-option has been identified as a key contributor to anti-angiogenic therapy resistance in CRCLMs. Recently, we identi...

  • Article
  • Open Access
4 Citations
3,029 Views
16 Pages

Pan-Cancer Characterization of Intratumoral Autonomic Innervation in 32 Cancer Types in the Cancer Genome Atlas

  • Jeff F. Zhang,
  • Haiyang Sheng,
  • Jianhong Chen,
  • Hemn Mohammadpour,
  • Sung Jun Ma,
  • Mark K. Farrugia,
  • Shipra Gandhi,
  • Elizabeth G. Bouchard,
  • Anurag K. Singh and
  • Song Yao
  • + 3 authors

21 May 2022

Over the past two decades, multiple studies have demonstrated the important role that the autonomic nervous system (ANS) plays in tumorigenesis and cancer progression. However, the mechanisms by which this process occurs have only recently begun to b...

  • Article
  • Open Access
13 Citations
3,787 Views
18 Pages

Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds

  • Qi Zhang,
  • Donghai Xiong,
  • Jing Pan,
  • Yian Wang,
  • Micael Hardy,
  • Balaraman Kalyanaraman and
  • Ming You

21 May 2022

Combined treatment targeting mitochondria may improve the efficacy of lung cancer chemoprevention. Here, mitochondria-targeted honokiol (Mito-HNK), an inhibitor of mitochondrial complex I and STAT3 phosphorylation, and mitochondria-targeted lonidamin...

  • Review
  • Open Access
40 Citations
10,254 Views
16 Pages

Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities

  • Katherina P. Farr,
  • Daniel Moses,
  • Koroush S. Haghighi,
  • Phoebe A. Phillips,
  • Claudia M. Hillenbrand and
  • Boon H. Chua

21 May 2022

Pancreatic cancer, one of the most lethal malignancies, is increasing in incidence. While survival rates for many cancers have improved dramatically over the last 20 years, people with pancreatic cancer have persistently poor outcomes. Potential cure...

  • Article
  • Open Access
24 Citations
4,883 Views
12 Pages

21 May 2022

Breast Cancer Awareness Month (BCAM) has a long history of over 30 years, established in 1985 to occur every October, and the National Breast Cancer Foundation now leads the operation. There have been no studies to evaluate the impact of the BCAM on...

  • Article
  • Open Access
38 Citations
4,689 Views
14 Pages

Artificial Intelligence Enhances Diagnostic Flow Cytometry Workflow in the Detection of Minimal Residual Disease of Chronic Lymphocytic Leukemia

  • Mohamed E. Salama,
  • Gregory E. Otteson,
  • Jon J. Camp,
  • Jansen N. Seheult,
  • Dragan Jevremovic,
  • David R. Holmes,
  • Horatiu Olteanu and
  • Min Shi

21 May 2022

Flow cytometric (FC) immunophenotyping is critical but time-consuming in diagnosing minimal residual disease (MRD). We evaluated whether human-in-the-loop artificial intelligence (AI) could improve the efficiency of clinical laboratories in detecting...

  • Review
  • Open Access
38 Citations
9,111 Views
18 Pages

Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy

  • Ahmet Kaynak,
  • Harold W. Davis,
  • Andrei B. Kogan,
  • Jing-Huei Lee,
  • Daria A. Narmoneva and
  • Xiaoyang Qi

21 May 2022

Cancer is among the leading causes of death worldwide. In recent years, many cancer-associated biomarkers have been identified that are used for cancer diagnosis, prognosis, screening, and early detection, as well as for predicting and monitoring car...

  • Article
  • Open Access
3 Citations
2,749 Views
13 Pages

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer

  • Shuhei Hirano,
  • Kazumasa Matsumoto,
  • Kei Tanaka,
  • Noriyuki Amano,
  • Dai Koguchi,
  • Masaomi Ikeda,
  • Yuriko Shimizu,
  • Benio Tsuchiya,
  • Ryo Nagashio and
  • Masatsugu Iwamura
  • + 1 author

21 May 2022

The overexpression of DJ-1 protein and its secretion into the bloodstream has been reported in various neoplasms. However, serum levels and the subcellular localization of DJ-1 have not been analyzed in detail in bladder cancer (BC). Our comprehensiv...

  • Review
  • Open Access
10 Citations
6,064 Views
12 Pages

21 May 2022

The most recent two decades have seen tremendous progress in the understanding and treatment of chronic myeloid leukemia, a disease defined by the characteristic Philadelphia chromosome and the ensuing BCR::ABL fusion protein. However, the biology of...

  • Article
  • Open Access
3 Citations
2,356 Views
15 Pages

Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients

  • Madeline Devaux,
  • Mathieu Boulin,
  • Morgane Mounier,
  • Denis Caillot,
  • Nuri Ahwij,
  • Adélie Herbin,
  • Jean Noël Bastie,
  • Camille Favennec,
  • Philippine Robert and
  • Pauline Gueneau
  • + 6 authors

21 May 2022

Objectives: The UMACOACH Lymphoma is a multidisciplinary monitoring program for patients initiating a first highly haematotoxic treatment for Hodgkin or non-Hodgkin lymphoma. Patient follow-up is based on consultation with a pharmacist and planed pho...

  • Review
  • Open Access
6 Citations
3,552 Views
17 Pages

20 May 2022

The idea of using tumor-specific cell-free DNA (ctDNA) as a tumor biomarker has been widely tested and validated in various types of human cancers and different clinical settings. ctDNA can reflect the presence or size of tumors in a real-time manner...

  • Article
  • Open Access
9 Citations
4,897 Views
29 Pages

Deep Learning for Reaction-Diffusion Glioma Growth Modeling: Towards a Fully Personalized Model?

  • Corentin Martens,
  • Antonin Rovai,
  • Daniele Bonatto,
  • Thierry Metens,
  • Olivier Debeir,
  • Christine Decaestecker,
  • Serge Goldman and
  • Gaetan Van Simaeys

20 May 2022

Reaction-diffusion models have been proposed for decades to capture the growth of gliomas, the most common primary brain tumors. However, ill-posedness of the initialization at diagnosis time and parameter estimation of such models have restrained th...

  • Article
  • Open Access
16 Citations
4,700 Views
12 Pages

A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma

  • Irene Dell’Anno,
  • Alessandra Melani,
  • Sarah A. Martin,
  • Marcella Barbarino,
  • Roberto Silvestri,
  • Monica Cipollini,
  • Antonio Giordano,
  • Luciano Mutti,
  • Andrea Nicolini and
  • Stefano Landi
  • + 3 authors

20 May 2022

The lack of effective therapies remains one of the main challenges for malignant pleural mesothelioma (MPM). In this perspective, drug repositioning could accelerate the identification of novel treatments. We screened 1170 FDA-approved drugs on a SV4...

  • Article
  • Open Access
12 Citations
3,406 Views
18 Pages

diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C2-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation

  • Chien-Chih Chiu,
  • Yen-Chun Chen,
  • Yung-Ding Bow,
  • Jeff Yi-Fu Chen,
  • Wangta Liu,
  • Jau-Ling Huang,
  • En-De Shu,
  • Yen-Ni Teng,
  • Chang-Yi Wu and
  • Wen-Tsan Chang

20 May 2022

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is the leading cause of cancer-related mortality worldwide. Chemotherapy is the major treatment modality for advanced or unresectable HCC; unfortunately, chemoresistance results in...

  • Article
  • Open Access
7 Citations
3,828 Views
14 Pages

Influence of Malignant Pleural Fluid from Lung Adenocarcinoma Patients on Neutrophil Response

  • Maria Mulet,
  • Rubén Osuna-Gómez,
  • Carlos Zamora,
  • José M. Porcel,
  • Juan C. Nieto,
  • Lídia Perea,
  • Virginia Pajares,
  • Ana M. Muñoz-Fernandez,
  • Nuria Calvo and
  • Silvia Vidal
  • + 1 author

20 May 2022

Malignant pleural effusion (MPE) is a common severe complication of advanced lung adenocarcinoma (LAC). Neutrophils, an essential component of tumor infiltrates, contribute to tumor progression and their counts in MPE have been associated with worse...

  • Article
  • Open Access
13 Citations
3,061 Views
13 Pages

Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life

  • Eryk Latoch,
  • Katarzyna Konończuk,
  • Karolina Konstantynowicz-Nowicka,
  • Katarzyna Muszyńska-Rosłan,
  • Klaudia Sztolsztener,
  • Adrian Chabowski and
  • Maryna Krawczuk-Rybak

20 May 2022

Childhood acute lymphoblastic leukemia (ALL) survivors are at higher risk of developing many late effects later in life. They experience multiple health problems that have significant public health implications, such as frailty, premature onset of li...

  • Article
  • Open Access
86 Citations
5,641 Views
12 Pages

Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People

  • Jun-Ook Park,
  • Inn-Chul Nam,
  • Choung-Soo Kim,
  • Sung-Joon Park,
  • Dong-Hyun Lee,
  • Hyun-Bum Kim,
  • Kyung-Do Han and
  • Young-Hoon Joo

20 May 2022

Background: Descriptive epidemiologists have repeatedly reported that males are more susceptible to head and neck cancers. However, most published data are those of cross-sectional studies, and no population-based cohort study has yet been published....

  • Review
  • Open Access
22 Citations
6,145 Views
17 Pages

IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies

  • Wojciech Wiese,
  • Natalia Siwecka,
  • Adam Wawrzynkiewicz,
  • Wioletta Rozpędek-Kamińska,
  • Ewa Kucharska and
  • Ireneusz Majsterek

20 May 2022

Synthesis, folding, and structural maturation of proteins occur in the endoplasmic reticulum (ER). Accumulation of misfolded or unfolded proteins in the ER lumen contributes to the induction of ER stress and activation of the unfolded protein respons...

  • Article
  • Open Access
25 Citations
4,337 Views
16 Pages

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response

  • Bernardo Leon Rapoport,
  • Simon Nayler,
  • Bernhard Mlecnik,
  • Teresa Smit,
  • Liezl Heyman,
  • Isabelle Bouquet,
  • Marine Martel,
  • Jérôme Galon,
  • Carol-Ann Benn and
  • Ronald Anderson

20 May 2022

Background: Tumor-infiltrating lymphocytes are associated with a better prognosis in early triple-negative breast cancer (TNBC). These cells can be enumerated in situ by the “Immunoscore Clinical Research” (ISCR). The original Immunoscore...

  • Article
  • Open Access
7 Citations
3,027 Views
18 Pages

Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study

  • Jingwen Yao,
  • Akifumi Hagiwara,
  • Talia C. Oughourlian,
  • Chencai Wang,
  • Catalina Raymond,
  • Whitney B. Pope,
  • Noriko Salamon,
  • Albert Lai,
  • Matthew Ji and
  • Benjamin M. Ellingson
  • + 3 authors

20 May 2022

Characterization of hypoxia and tissue acidosis could advance the understanding of glioma biology and improve patient management. In this study, we evaluated the ability of a pH- and oxygen-sensitive magnetic resonance imaging (MRI) technique to diff...

  • Article
  • Open Access
9 Citations
2,570 Views
9 Pages

The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer

  • Caleb J. Euhus,
  • Taylor R. Ripley and
  • Cristian G. Medina

20 May 2022

Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited number of metastatic sites. It is analogous to an intermediate stage of NSCLC, between localized and widely metastatic disease, even though no staging c...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694